Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Effectiveness, safety, and clinical outcomes of treatment with the oral α4-integrin antagonist carotegrast methyl in patients with active ulcerative colitis: a multicenter observational study (CANAL study).

BACKGROUND Carotegrast methyl is an oral α4-integrin antagonist used to induce remission in patients with ulcerative colitis with an inadequate response to 5-aminosalicylate (5-ASA). This multicenter, retrospective observational study evaluated the clinical usefulness of carotegrast methyl in real-world practice. MET...

F. Hirai, K. Matsuoka, Kenji Watanabe et al. · 0 citations
Open access Aug 2026

Efficacy and safety of upadacitinib for Crohn's disease in patients in East Asia: a post hoc analysis of randomized phase 3 studies.

BACKGROUND Upadacitinib is an oral Janus kinase inhibitor approved for the treatment of moderate-to-severe Crohn's disease (CD). This post hoc analysis reports the efficacy and safety of upadacitinib for CD in patients in East Asia enrolled in the phase 3 clinical trials. METHODS In two induction studies (U-EXCEL [NC...

Min-Hu Chen, Xiang Gao, Kenji Watanabe et al. · 0 citations
Review Sep 2026

Serum soluble Fas levels and incidence of biliary tract cancer in a nested case-control study.

High serum sFas may be related to future risk of extrahepatic biliary tract cancer in a prospective case-control study nested in the Japan Collaborative Cohort study, highlighting the need for additional studies of this biomarker in large prospective cohorts and through integrated analysis involving other cohorts.

Yasushi Adachi, M. Nojima, Ying-Song Lin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.